ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
ICAD (Intracranial Atherosclerotic Disease) Pathology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-11Q13104
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global ICAD Intracranial Atherosclerotic Disease Pathology Market Research Report 2023
BUY CHAPTERS

ICAD (Intracranial Atherosclerotic Disease) Pathology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-11Q13104
Report
March 2024
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Stryker
Balt
Terumo
MicroPort
Acandis GmbH

ICAD (Intracranial Atherosclerotic Disease) Pathology - Market Size

The global market for ICAD (Intracranial Atherosclerotic Disease) Pathology was estimated to be worth US$ 174 million in 2023 and is forecast to a readjusted size of US$ 316.2 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030

ICAD (Intracranial Atherosclerotic Disease) Pathology - Market

ICAD (Intracranial Atherosclerotic Disease) Pathology - Market

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.
Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for ICAD (Intracranial Atherosclerotic Disease) Pathology, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology by region & country, by Type, and by Application.
The ICAD (Intracranial Atherosclerotic Disease) Pathology market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ICAD (Intracranial Atherosclerotic Disease) Pathology.
Market Segmentation

Scope of ICAD (Intracranial Atherosclerotic Disease) Pathology - Market Report

Report Metric Details
Report Name ICAD (Intracranial Atherosclerotic Disease) Pathology - Market
Forecasted market size in 2030 US$ 316.2 million
CAGR 8.8%
Forecasted years 2024 - 2030
Segment by Type:
  • Stent
  • PTA Balloon
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Stryker, Balt, TERUMO, MicroPort, Acandis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of ICAD (Intracranial Atherosclerotic Disease) Pathology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the ICAD (Intracranial Atherosclerotic Disease) Pathology - Market size in 2030?

Ans: The ICAD (Intracranial Atherosclerotic Disease) Pathology - Market size in 2030 will be US$ 316.2 million.

What is the market share of major companies in ICAD (Intracranial Atherosclerotic Disease) Pathology - Market?

Ans: Global top five manufacturers hold a share about 90%.

What is the ICAD (Intracranial Atherosclerotic Disease) Pathology - Market share by type?

Ans: In terms of product, Stent is the largest segment, with a share about 80%.

Who are the main players in the ICAD (Intracranial Atherosclerotic Disease) Pathology - Market report?

Ans: The main players in the ICAD (Intracranial Atherosclerotic Disease) Pathology - Market are Stryker, Balt, TERUMO, MicroPort, Acandis

What are the Application segmentation covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology - Market report?

Ans: The Applications covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology - Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology - Market report?

Ans: The Types covered in the ICAD (Intracranial Atherosclerotic Disease) Pathology - Market report are Stent, PTA Balloon

1 Market Overview
1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction
1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Forecast
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value (2019-2030)
1.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (2019-2030)
1.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price (2019-2030)
1.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Trends & Drivers
1.3.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
1.3.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers & Opportunity
1.3.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
1.3.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Players Revenue Ranking (2023)
2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company (2019-2024)
2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Players Sales Volume Ranking (2023)
2.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Company Players (2019-2024)
2.5 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price by Company (2019-2024)
2.6 Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of ICAD (Intracranial Atherosclerotic Disease) Pathology
2.9 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competitive Analysis
2.9.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Stent
3.1.2 PTA Balloon
3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type
3.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, by Type (2019-2030)
3.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, by Type (%) (2019-2030)
3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Type
3.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, by Type (2019-2030)
3.3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, by Type (%) (2019-2030)
3.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application
4.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, by Application (2019-2030)
4.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, by Application (%) (2019-2030)
4.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Application
4.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, by Application (2019-2030)
4.3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, by Application (%) (2019-2030)
4.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Region
5.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Region (2019-2024)
5.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Region (2025-2030)
5.1.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Region (%), (2019-2030)
5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Region
5.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Region (2019-2024)
5.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Region (2025-2030)
5.2.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Region (%), (2019-2030)
5.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, 2019-2030
5.4.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, 2019-2030
5.5.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, 2019-2030
5.6.2 Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, 2019-2030
5.7.2 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, 2019-2030
5.8.2 Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value
6.2.1 Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, 2019-2030
6.2.2 Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, 2019-2030
6.3 United States
6.3.1 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, 2019-2030
6.3.2 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, 2019-2030
6.4.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, 2019-2030
6.5.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (%), 2023 VS 2030
6.5.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, 2019-2030
6.6.2 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, 2019-2030
6.7.2 South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, 2019-2030
6.8.2 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, 2019-2030
6.9.2 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (%), 2023 VS 2030
6.9.3 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Stryker
7.1.1 Stryker Company Information
7.1.2 Stryker Introduction and Business Overview
7.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
7.1.5 Stryker Recent Development
7.2 Balt
7.2.1 Balt Company Information
7.2.2 Balt Introduction and Business Overview
7.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
7.2.5 Balt Recent Development
7.3 TERUMO
7.3.1 TERUMO Company Information
7.3.2 TERUMO Introduction and Business Overview
7.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
7.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
7.3.5 TERUMO Recent Development
7.4 MicroPort
7.4.1 MicroPort Company Information
7.4.2 MicroPort Introduction and Business Overview
7.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
7.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
7.4.5 MicroPort Recent Development
7.5 Acandis
7.5.1 Acandis Company Information
7.5.2 Acandis Introduction and Business Overview
7.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
7.5.5 Acandis Recent Development
8 Industry Chain Analysis
8.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industrial Chain
8.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Model
8.5.2 Sales Channel
8.5.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Stryker
Balt
Terumo
MicroPort
Acandis GmbH
List of Tables
    Table 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Trends
    Table 2. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers & Opportunity
    Table 3. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
    Table 4. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
    Table 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Company (2019-2024)
    Table 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Company (2019-2024) & (Units)
    Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of ICAD (Intracranial Atherosclerotic Disease) Pathology
    Table 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Type: 2019 VS 2023 VS 2030 (Units)
    Table 22. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Type (2019-2024) & (Units)
    Table 23. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Type (2025-2030) & (Units)
    Table 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Application: 2019 VS 2023 VS 2030 (Units)
    Table 34. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Application (2019-2024) & (Units)
    Table 35. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Application (2025-2030) & (Units)
    Table 36. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Region (2019-2024) & (%)
    Table 44. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Region (2025-2030) & (%)
    Table 45. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Region (Units): 2019 VS 2023 VS 2030
    Table 46. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Region (2019-2024) & (Units)
    Table 47. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Region (2025-2030) & (Units)
    Table 48. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Region (2019-2024) & (%)
    Table 49. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Region (2025-2030) & (%)
    Table 50. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, (2019-2024) & (Units)
    Table 56. Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume, (2025-2030) & (Units)
    Table 57. Stryker Company Information
    Table 58. Stryker Introduction and Business Overview
    Table 59. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
    Table 61. Stryker Recent Development
    Table 62. Balt Company Information
    Table 63. Balt Introduction and Business Overview
    Table 64. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
    Table 66. Balt Recent Development
    Table 67. TERUMO Company Information
    Table 68. TERUMO Introduction and Business Overview
    Table 69. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
    Table 71. TERUMO Recent Development
    Table 72. MicroPort Company Information
    Table 73. MicroPort Introduction and Business Overview
    Table 74. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
    Table 76. MicroPort Recent Development
    Table 77. Acandis Company Information
    Table 78. Acandis Introduction and Business Overview
    Table 79. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Offerings
    Table 81. Acandis Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. ICAD (Intracranial Atherosclerotic Disease) Pathology Downstream Customers
    Table 85. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Product Picture
    Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (2019-2030) & (Units)
    Figure 5. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Price (2019-2030) & (USD/Unit)
    Figure 6. ICAD (Intracranial Atherosclerotic Disease) Pathology Report Years Considered
    Figure 7. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Players Sales Volume Ranking (2023) & (Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue in 2023
    Figure 10. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Stent Picture
    Figure 12. PTA Balloon Picture
    Figure 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Type (2019 VS 2023 VS 2030) & (Units)
    Figure 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Clinic
    Figure 20. Product Picture of Other
    Figure 21. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume by Application (2019 VS 2023 VS 2030) & (Units)
    Figure 24. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2019-2030) & (USD/Unit)
    Figure 26. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Volume (%), (2019-2030)
    Figure 38. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application (%), 2023 VS 2030
    Figure 44. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (%), 2023 VS 2030
    Figure 46. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application (%), 2023 VS 2030
    Figure 56. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Type (%), 2023 VS 2030
    Figure 58. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Value by Application (%), 2023 VS 2030
    Figure 59. ICAD (Intracranial Atherosclerotic Disease) Pathology Industrial Chain
    Figure 60. ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Coronary Artery Imaging Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37R6046
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global ECG Devices Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23S9116
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Decentralized & POC Coagulation Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-7S6333
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Transcatheter Aortic Valve Implantation (TAVI) System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37M13084
Sun Apr 07 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions